Use of Monoclonal Antibodies in Pregnant Women Infected by COVID-19: A Case Series

Background: Monoclonal antibodies are designed to target specific proteins of COVID-19 and can be used as a treatment for people with mild to moderate infection and at a high risk of severe disease. Casirivimab/imdevimab, sotrovimab, and Bamlanivimab/etesevimab have been authorized for emergency use...

Descripción completa

Detalles Bibliográficos
Autores principales: Crispino, Pietro, Marocco, Raffaella, Di Trento, Daniela, Guarisco, Gloria, Kertusha, Blerta, Carraro, Anna, Corazza, Sara, Pane, Cristina, Di Troia, Luciano, del Borgo, Cosimo, Lichtner, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459383/
https://www.ncbi.nlm.nih.gov/pubmed/37630512
http://dx.doi.org/10.3390/microorganisms11081953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459383/
https://www.ncbi.nlm.nih.gov/pubmed/37630512
http://dx.doi.org/10.3390/microorganisms11081953

Ejemplares similares